GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Traws Pharma Inc (STU:0T2) » Definitions » PB Ratio

Traws Pharma (STU:0T2) PB Ratio : 1.22 (As of May. 06, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Traws Pharma PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-06), Traws Pharma's share price is €0.57. Traws Pharma's Book Value per Share for the quarter that ended in Dec. 2023 was €0.47. Hence, Traws Pharma's PB Ratio of today is 1.22.

The historical rank and industry rank for Traws Pharma's PB Ratio or its related term are showing as below:

STU:0T2' s PB Ratio Range Over the Past 10 Years
Min: 0.4   Med: 2.37   Max: 49.25
Current: 1.25

During the past 13 years, Traws Pharma's highest PB Ratio was 49.25. The lowest was 0.40. And the median was 2.37.

STU:0T2's PB Ratio is ranked better than
75.27% of 1314 companies
in the Biotechnology industry
Industry Median: 2.505 vs STU:0T2: 1.25

During the past 12 months, Traws Pharma's average Book Value Per Share Growth Rate was -62.50% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 0.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -36.00% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Traws Pharma was 0.70% per year. The lowest was -77.80% per year. And the median was -60.30% per year.

Back to Basics: PB Ratio


Traws Pharma PB Ratio Historical Data

The historical data trend for Traws Pharma's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Traws Pharma PB Ratio Chart

Traws Pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.48 12.69 1.11 0.46 1.39

Traws Pharma Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.64 1.17 1.02 1.39

Competitive Comparison of Traws Pharma's PB Ratio

For the Biotechnology subindustry, Traws Pharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Traws Pharma's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Traws Pharma's PB Ratio distribution charts can be found below:

* The bar in red indicates where Traws Pharma's PB Ratio falls into.



Traws Pharma PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Traws Pharma's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=0.57/0.466
=1.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Traws Pharma  (STU:0T2) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Traws Pharma PB Ratio Related Terms

Thank you for viewing the detailed overview of Traws Pharma's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Traws Pharma (STU:0T2) Business Description

Traded in Other Exchanges
Address
12 Penns Trail, Newtown, PA, USA, 18940
Onconova Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel products to treat cancer. The company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova's novel, proprietary multi-kinase inhibitor ON 123300 is currently in a dose-escalation and expansion Phase 1 trial in China, and an IND has been filed in the U.S. Its product candidate oral rigosertib is currently in a dose-escalation and expansion Phase 1 investigator-initiated study targeting patients with KRAS+ lung adenocarcinoma in combination with nivolumab.

Traws Pharma (STU:0T2) Headlines

No Headlines